Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Deray

Showing results (211-220 of 213) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 213 results.
Clinical Journal of the American Society of Nephrology : CJASN|September 1, 2012
L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trialLucile Mercadal, Mathieu Coudert, Anne Vassault, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortalityNeil C Boudville, Ognjenka Djurdjev, Iain C Macdougall, et al.
Bulletin Du Cancer|November 26, 2015
[Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria]Vincent Launay-Vacher, Nicolas Janus, Philippe Beuzeboc, et al.
Pageof 22

Showing results (211-220 of 213) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 213 results.
Clinical Journal of the American Society of Nephrology : CJASN|September 1, 2012
L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trialLucile Mercadal, Mathieu Coudert, Anne Vassault, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 9, 2009
Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortalityNeil C Boudville, Ognjenka Djurdjev, Iain C Macdougall, et al.
Bulletin Du Cancer|November 26, 2015
[Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria]Vincent Launay-Vacher, Nicolas Janus, Philippe Beuzeboc, et al.
Pageof 22